BBP vs. FHLC

Last updated Apr 1, 2026

Compare and contrast key facts about Virtus LifeSci Biotech Products ETF (BBP) and Fidelity MSCI Health Care Index ETF (FHLC).

BBP and FHLC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. FHLC is a passively managed fund by Fidelity that tracks the performance of the MSCI USA IMI Health Care Index. It was launched on Oct 21, 2013. Both BBP and FHLC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

BBP vs. FHLC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Fidelity MSCI Health Care Index ETF (FHLC). The values are adjusted to include any dividend payments, if applicable.

BBP vs. FHLC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBP Virtus LifeSci Biotech Products ETF	3.94%	33.15%	3.32%	17.88%	0.85%	-8.17%	22.24%	24.73%	-13.95%	24.07%
FHLC Fidelity MSCI Health Care Index ETF	-4.97%	15.42%	2.48%	2.58%	-5.55%	20.39%	18.13%	21.94%	4.71%	23.34%

Returns By Period

In the year-to-date period, BBP achieves a 3.94% return, which is significantly higher than FHLC's -4.97% return. Over the past 10 years, BBP has outperformed FHLC with an annualized return of 12.76%, while FHLC has yielded a comparatively lower 9.60% annualized return.

BBP

• 1D: 5.93%
• 1M: -2.16%
• YTD: 3.94%
• 6M: 18.71%
• 1Y: 41.70%
• 3Y*: 19.01%
• 5Y*: 9.37%
• 10Y*: 12.76%

FHLC

• 1D: 2.28%
• 1M: -7.46%
• YTD: -4.97%
• 6M: 5.95%
• 1Y: 4.53%
• 3Y*: 6.14%
• 5Y*: 5.07%
• 10Y*: 9.60%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. FHLC - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than FHLC's 0.08% expense ratio.

BBP

Virtus LifeSci Biotech Products ETF

FHLC

Fidelity MSCI Health Care Index ETF

Return for Risk

BBP vs. FHLC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP

BBP Risk / Return Rank: 82
BBP Sharpe Ratio Rank: 81
BBP Sortino Ratio Rank: 83
BBP Omega Ratio Rank: 73
BBP Calmar Ratio Rank: 87
BBP Martin Ratio Rank: 87

FHLC

FHLC Risk / Return Rank: 21
FHLC Sharpe Ratio Rank: 20
FHLC Sortino Ratio Rank: 20
FHLC Omega Ratio Rank: 19
FHLC Calmar Ratio Rank: 25
FHLC Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. FHLC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBP	FHLC	Difference
Sharpe ratio Return per unit of total volatility	1.55	0.26	+1.29
Sortino ratio Return per unit of downside risk	2.18	0.48	+1.71
Omega ratio Gain probability vs. loss probability	1.27	1.06	+0.21
Calmar ratio Return relative to maximum drawdown	2.69	0.51	+2.18
Martin ratio Return relative to average drawdown	10.18	1.08	+9.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBP vs. FHLC - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 1.55, which is higher than the FHLC Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of BBP and FHLC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BBP	FHLC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.55	0.26	+1.29
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.36	0.34	+0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.47	0.57	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.61	-0.22

Correlation

The correlation between BBP and FHLC is 0.70, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

BBP vs. FHLC - Dividend Comparison

BBP has not paid dividends to shareholders, while FHLC's dividend yield for the trailing twelve months is around 1.44%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBP Virtus LifeSci Biotech Products ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.00%	1.29%
FHLC Fidelity MSCI Health Care Index ETF	1.44%	1.40%	1.51%	1.40%	1.30%	1.16%	1.45%	1.18%	1.38%	1.38%	1.40%	2.07%

Drawdowns

BBP vs. FHLC - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for BBP and FHLC.

Drawdown Indicators

	BBP	FHLC	Difference
Max Drawdown Largest peak-to-trough decline	-44.32%	-28.76%	-15.56%
Max Drawdown (1Y) Largest decline over 1 year	-13.38%	-10.38%	-3.00%
Max Drawdown (5Y) Largest decline over 5 years	-38.28%	-17.73%	-20.55%
Max Drawdown (10Y) Largest decline over 10 years	-44.32%	-28.76%	-15.56%
Current Drawdown Current decline from peak	-3.90%	-7.99%	+4.09%
Average Drawdown Average peak-to-trough decline	-12.16%	-5.16%	-7.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.72%	5.04%	-1.32%

Volatility

BBP vs. FHLC - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 11.21% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 5.14%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBP	FHLC	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.21%	5.14%	+6.07%
Volatility (6M) Calculated over the trailing 6-month period	18.03%	10.26%	+7.77%
Volatility (1Y) Calculated over the trailing 1-year period	27.16%	17.61%	+9.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.23%	14.85%	+11.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.51%	16.82%	+10.69%